Health Care Tech

Dr. Amesh Adalja discusses the role of the COVID vaccine as new variants emerge on ‘Kennedy.’

Joel Marcus, executive chairman and founder of Alexandria Real Estate Equities, says the 2022 pipeline includes more than 8 million square feet in active development with more than 80% leased. 

Prophase CEO Ted Karkus says the testing company has ramped up staffing efforts as COVID testing demand surges.

Arkansas Gov. Asa Hutchinson argues Biden needs to get at-home COVID-19 testing kits 'produced' and sent to the states for distribution.

Rep. Greg Steube, R-Fla., argues 'you can't believe any of the information' that comes out of the Centers for Disease Control and Prevention. 

Gov. Asa Hutchinson, R-Ark., on rising omicron cases in his state, Biden claiming the solution to the virus is at the state level and Florida Gov. Ron DeSantis' handling of COVID testing.

Mt. Sinai Hospital Icahn School of Medicine Dr. Joel Zinburg discusses the CDC's mixed messaging on COVID guidelines and testing, the omicron variant and NYC considering race when distributing life-saving COVID treatments. 

Northwell Health Internist Dr. Frank Contacessa discusses the Chicago Teachers Unions shutting down in-person learning over rising COVID cases, booster shots, omicron variant and the latest IHU variant emerging in France.

eMed co-founder and CEO Dr. Patrice Harris says the U.S. needs a better at-home testing protocol.

Intrivo co-CEO Ron Gutman says their at-home COVID tests are available online and at select retailers.

Intrivo co-CEO Ron Gutman discusses ‘2Gather,’ an at-home rapid test result meant to be taken ahead of gatherings.

Fox News contributor Dr. Janette Nesheiwat says the vaccine remains the most effective in the fight against COVID.

Novavax CEO Stanley Erck says the company will file with the U.S. Food and Drug Administration before the end of the year.

Co-Diagnostics CEO Dwight Egan says his company is 'on the fast track' to make the tests available, noting that clinical trials should be complete in the first quarter and then will be submitted to the FDA for approval. 

Novavax CEO Stanley Erck says the company is in the process of manufacturing 'quite a bit of doses and getting them out' and notes that the vaccine will be 'very effective' against the omicron strain.

Opteev Technologies co-founder and CEO Conrad Bessemer shares details on new coronavirus detection technology.

Dr. Nicole Saphier says the treatment is a ‘massive tool’ to reach an ‘endemic’ state on ‘Kennedy.’

‘Kennedy’ party panel discusses the administration’s omicron readiness as cases surge.